Natural Capsules

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE936B01015
  • NSEID: NATCAPSUQ
  • BSEID: 524654
INR
152.85
-11.4 (-6.94%)
BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 30.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 349207,
    "name": "Natural Capsules",
    "stock_name": "Natural Capsules",
    "full_name": "Natural Capsules Ltd",
    "name_url": "stocks-analysis/natural-capsules",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "152.85",
    "chg": -11.4,
    "chgp": "-6.94%",
    "dir": -1,
    "prev_price": "164.25",
    "mcapval": "162.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524654,
    "symbol": "NATCAPSUQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE936B01015",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "03:32 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "30.84 k",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natural-capsules-349207-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Natural Capsules Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natural-capsules-ltd-is-rated-strong-sell-4124087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NaturalCapsules_mojoScore_4124087.png",
        "date": "2026-07-28 10:11:13",
        "description": "Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 28 July 2026, providing investors with the latest insights into the stock’s performance and prospects."
      },
      {
        "title": "Natural Capsules Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natural-capsules-ltd-is-rated-strong-sell-4106235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NaturalCapsules_mojoScore_4106235.png",
        "date": "2026-07-17 10:10:42",
        "description": "Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 July 2026, providing investors with the most up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Natural Capsules Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natural-capsules-ltd-is-rated-strong-sell-4090620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NaturalCapsules_mojoScore_4090620.png",
        "date": "2026-07-06 10:10:31",
        "description": "Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 July 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Natural Capsules Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natural-capsules-ltd-is-rated-strong-sell-4073087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NaturalCapsules_mojoScore_4073087.png",
        "date": "2026-06-25 10:10:38",
        "description": "Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 25 June 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Natural Capsules Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natural-capsules-ltd-is-rated-strong-sell-4052801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NaturalCapsules_mojoScore_4052801.png",
        "date": "2026-06-14 10:10:16",
        "description": "Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Natural Capsules Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natural-capsules-ltd-is-rated-strong-sell-4024349",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NaturalCapsules_mojoScore_4024349.png",
        "date": "2026-05-31 10:10:18",
        "description": "Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Natural Capsules Gains 5.68%: Margin Pressures and Flat Quarterly Results Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natural-capsules-gains-568-margin-pressures-and-flat-quarterly-results-shape-the-week-4023619",
        "imagepath": "",
        "date": "2026-05-30 17:20:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 25:</strong> Stock rises 0.72% amid positive market sentiment</p>\n                    <p><strong>May 26:</strong> Stock dips 1.94% on lower volume and market weakness</p>\n                    <p><strong>May 27:</strong> Sharp 12.20% rally following positive trading momentum</p>\n                    <p><strong>May 29:</strong> Quarterly results reveal flat performance and margin pressures; stock falls 4.63%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.153.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</di..."
      },
      {
        "title": "Natural Capsules Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natural-capsules-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4020236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NaturalCapsules_fintrenddot_4020236.png",
        "date": "2026-05-29 11:01:17",
        "description": "Natural Capsules Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, signalling a pause in its previously negative trend. Despite achieving its highest quarterly net sales to date, the company faces mounting challenges from increased interest expenses and a deteriorating debt-equity ratio, prompting a downgrade to a Strong Sell rating by MarketsMOJO."
      },
      {
        "title": "Natural Capsules Q4 FY26: Mounting Losses Signal Deepening Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/natural-capsules-q4-fy26-mounting-losses-signal-deepening-crisis-4022049",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NaturalCapsules_quaterlyResult_4022049.png",
        "date": "2026-05-29 10:04:48",
        "description": "Natural Capsules Ltd., a Bangalore-based manufacturer of hard capsule shells, reported a consolidated net loss of ₹3.45 crores for Q4 FY26, marking the fourth consecutive quarter of losses and deepening concerns about the company's operational viability. The ₹168.26 crore market cap company saw its stock decline 4.54% to ₹162.00 following the results announcement, extending a brutal 28.26% decline over the past year."
      }
    ],
    "total": 191,
    "sid": "349207",
    "stock_news_url": "https://www.marketsmojo.com/news/natural-capsules-349207"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "31-Jul-2026",
      "details": "Natural Biogenex Private Limited (Material Unlisted Subsidiary) at its Board Meeting held on today i.e. July 31 2026 has approved the Allotment of the Right Issue duly approved on Board Meeting dated on July 10 2026 of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Dilution Of Equity Shareholding In Subsidiary Company Due To Non-Participation In Rights Issue.",
      "datetime": "29-Jul-2026",
      "details": "Board of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July 2026 and the final majority vote was received by 08:00 PM decided not to subscribe to the Right Issue offered by its subsidiary company Natural Biogenex Private Limited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Jul-2026",
      "details": "Newspaper Publication for Completion of Dispatch of Notice of 33rd Annual General Meeting and Annual Report for F.Y 2025-26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natural Capsules Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Jul 23",
          "dt": "2023-07-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Natural Capsules Ltd has announced <strong>1:2</strong> rights issue, ex-date: 11 Nov 21",
          "dt": "2021-11-11",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Natural Capsules Gains 5.68%: Margin Pressures and Flat Quarterly Results Shape the Week

2026-05-30 17:20:14
stock-recommendationAnnouncement

Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

31-Jul-2026 | Source : BSE

Natural Biogenex Private Limited (Material Unlisted Subsidiary) at its Board Meeting held on today i.e. July 31 2026 has approved the Allotment of the Right Issue duly approved on Board Meeting dated on July 10 2026 of the Company.

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Dilution Of Equity Shareholding In Subsidiary Company Due To Non-Participation In Rights Issue.

29-Jul-2026 | Source : BSE

Board of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July 2026 and the final majority vote was received by 08:00 PM decided not to subscribe to the Right Issue offered by its subsidiary company Natural Biogenex Private Limited.

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Jul-2026 | Source : BSE

Newspaper Publication for Completion of Dispatch of Notice of 33rd Annual General Meeting and Annual Report for F.Y 2025-26.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Natural Capsules Ltd has declared 10% dividend, ex-date: 20 Jul 23

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Natural Capsules Ltd has announced 1:2 rights issue, ex-date: 11 Nov 21